Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer
2018; American Medical Association; Volume: 4; Issue: 4 Linguagem: Inglês
10.1001/jamaoncol.2017.5524
ISSN2374-2445
AutoresIvana Šestak, Richard Buus, Jack Cuzick, Peter Dubsky, Ralf Kronenwett, Carsten Denkert, Sean Ferree, Dennis C. Sgroi, Catherine A. Schnabel, Frederick L. Baehner, Elizabeth Mallon, Mitch Dowsett,
Tópico(s)BRCA gene mutations in cancer
ResumoMultiple molecular signatures are available for managing estrogen receptor (ER)-positive breast cancer but with little direct comparative information to guide the patient's choice.
Referência(s)